Folate levels determine effect of antioxidant supplementation on micronuclei in subjects with cardiovascular risk

By Smolková B.  

Mutagenesis, Vol. 19, Iss. 6, 2004-11 ,pp. : 469-476

Oxford University Press

Access to resources Recommend Favorite

Biomarkers of oxidative damage are elevated among individuals with high cardiovascular risk: Refining subject selection strategies for antioxidant trials

By Seet Raymond C.S.   Quek Amy M.L.   Lim Erle C.H.   Halliwell Barry  

Free Radical Research, Vol. 47, Iss. 4, 2013-04 ,pp. : 283-290

Informa Healthcare

Access to resources Recommend Favorite

Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials

By Derosa Giuseppe   Maffioli Pamela   Cicero Arrigo FG  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 8, 2012-08 ,pp. : 1113-1124

Informa Healthcare

Access to resources Recommend Favorite

Promising clinical trials on kinase inhibitor

By Boer J.d.  

Trends in Cell Biology, Vol. 11, Iss. 3, 2001-03 ,pp. : 110-110

Elsevier

Access to resources Recommend Favorite

The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity

By Lonnrot K.   Metsa-Ketela T.   Molnar G.   Ahonen J.-P.   Latvala M.   Peltola J.   Pietila T.   Alho H.  

Free Radical Biology and Medicine, Vol. 21, Iss. 2, 1996-01 ,pp. : 211-217

Elsevier

Access to resources Recommend Favorite